Yüklüyor......

The diffuse large B-cell lymphoma – where do we stand now in everyday clinical practice

BACKGROUND: Due to superior results observed with the addition of rituximab into treatment of patients with the diffuse large B-cell lymphoma (DLBCL),the R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) regimen and its variants became the standard initial treatment of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Gregoric, Brigita, Zadnik, Vesna, Jezersek Novakovic, Barbara
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Versita, Warsaw 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3472942/
https://ncbi.nlm.nih.gov/pubmed/23077452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/v10019-012-0002-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!